49 related articles for article (PubMed ID: 12637330)
1. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
[TBL] [Abstract][Full Text] [Related]
2. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
[TBL] [Abstract][Full Text] [Related]
3. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.
Castella M; Pujol R; Callén E; Trujillo JP; Casado JA; Gille H; Lach FP; Auerbach AD; Schindler D; Benítez J; Porto B; Ferro T; Muñoz A; Sevilla J; Madero L; Cela E; Beléndez C; de Heredia CD; Olivé T; de Toledo JS; Badell I; Torrent M; Estella J; Dasí A; Rodríguez-Villa A; Gómez P; Barbot J; Tapia M; Molinés A; Figuera A; Bueren JA; Surrallés J
Blood; 2011 Apr; 117(14):3759-69. PubMed ID: 21273304
[TBL] [Abstract][Full Text] [Related]
4. A strategy for molecular diagnostics of Fanconi anemia in Brazilian patients.
Pilonetto DV; Pereira NF; Bonfim CMS; Ribeiro LL; Bitencourt MA; Kerkhoven L; Floor K; Ameziane N; Joenje H; Gille JJP; Pasquini R
Mol Genet Genomic Med; 2017 Jul; 5(4):360-372. PubMed ID: 28717661
[TBL] [Abstract][Full Text] [Related]
5. Novel
Repczynska A; Pastorczak A; Babol-Pokora K; Skalska-Sadowska J; Drozniewska M; Mlynarski W; Haus O
Mol Cytogenet; 2020; 13():33. PubMed ID: 32793304
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing.
Gille JJ; Floor K; Kerkhoven L; Ameziane N; Joenje H; de Winter JP
Anemia; 2012; 2012():603253. PubMed ID: 22778927
[TBL] [Abstract][Full Text] [Related]
7. Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway.
Padella A; Fontana MC; Marconi G; Fonzi E; Petracci E; Ferrari A; Baldazzi C; Papayannidis C; Ghelli Luserna Di Rorá A; Testoni N; Castellani G; Haferlach T; Martinelli G; Simonetti G
Blood Cancer J; 2021 Jan; 11(1):7. PubMed ID: 33414401
[No Abstract] [Full Text] [Related]
8. Correction to: Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4525. PubMed ID: 37688684
[No Abstract] [Full Text] [Related]
9. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.
Tseng PH; Matsuzawa A; Zhang W; Mino T; Vignali DA; Karin M
Nat Immunol; 2010 Jan; 11(1):70-5. PubMed ID: 19898473
[TBL] [Abstract][Full Text] [Related]
10. Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates: roles of endoplamic reticulum-bound p97/Cdc48p and proteasome.
Elkabetz Y; Shapira I; Rabinovich E; Bar-Nun S
J Biol Chem; 2004 Feb; 279(6):3980-9. PubMed ID: 14607830
[TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia.
Chang L; Zhang L; Zhao B; Cheng X; Wan Y; Zhang R; Yuan W; Gao X; Zhu X
BMC Med Genomics; 2023 Nov; 16(1):290. PubMed ID: 37974167
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients.
Yao H; Wu C; Chen Y; Guo L; Chen W; Pan Y; Fu X; Wang G; Ding Y
Mol Genet Genomic Med; 2020 Sep; 8(9):e1369. PubMed ID: 32638549
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in understanding hematopoiesis in Fanconi Anemia.
Bagby G
F1000Res; 2018; 7():105. PubMed ID: 29399332
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of genome stability by Fanconi anemia proteins.
Palovcak A; Liu W; Yuan F; Zhang Y
Cell Biosci; 2017; 7():8. PubMed ID: 28239445
[TBL] [Abstract][Full Text] [Related]
15. Leukemic survival factor SALL4 contributes to defective DNA damage repair.
Wang F; Gao C; Lu J; Tatetsu H; Williams DA; Müller LU; Cui W; Chai L
Oncogene; 2016 Nov; 35(47):6087-6095. PubMed ID: 27132514
[TBL] [Abstract][Full Text] [Related]
16. Cytokine overproduction and crosslinker hypersensitivity are unlinked in Fanconi anemia macrophages.
Garbati MR; Hays LE; Rathbun RK; Jillette N; Chin K; Al-Dhalimy M; Agarwal A; Newell AE; Olson SB; Bagby GC
J Leukoc Biol; 2016 Mar; 99(3):455-65. PubMed ID: 26432900
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.
Litim N; Labrie Y; Desjardins S; Ouellette G; Plourde K; Belleau P; ; Durocher F
Mol Oncol; 2013 Feb; 7(1):85-100. PubMed ID: 23021409
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anaemia: from a monogenic disease to sporadic cancer.
Valeri A; Martínez S; Casado JA; Bueren JA
Clin Transl Oncol; 2011 Apr; 13(4):215-21. PubMed ID: 21493181
[TBL] [Abstract][Full Text] [Related]
19. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
Beck AH; Lee CH; Witten DM; Gleason BC; Edris B; Espinosa I; Zhu S; Li R; Montgomery KD; Marinelli RJ; Tibshirani R; Hastie T; Jablons DM; Rubin BP; Fletcher CD; West RB; van de Rijn M
Oncogene; 2010 Feb; 29(6):845-54. PubMed ID: 19901961
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin system, disease, and drug discovery.
Petroski MD
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S7. PubMed ID: 19007437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
